Access to clinical trial information and the stockpiling of Tamiflu

Access to clinical trial information and the stockpiling of Tamiflu: This study follows correspondence from a number of MPs raising questions about access to all clinical trials information for UK regulators when licensing and appraising new medicines; and the decision to stockpile Tamiflu. We will examine whether:

• regulators / NICE assure themselves that they have all clinical trials evidence when licensing and appraising new drugs to be used in the NHS
• all the clinical trials information was available to regulators when they licensed Tamiflu and when NICE undertook its technology appraisal of Tamiflu
• the NHS stockpiled Tamiflu for the treatment of avian and swine flu on the basis of clinical evidence, and on the advice of the appropriate authorities

 Email Angharad through our enquiries desk; please mark your email for her attention. National Audit Office